No insider purchase over the last 90 days. The latest, by HAGGERTY GRETCHEN R, was filed 07 Aug 2025.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate Teleflex Inc Buy (bullish), based on 11 analysts. Average price target: US$154.00.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 828 declarations
At Teleflex Inc, a US healthcare company valued at USD 5.56 billion, the 284 sales total EUR 141,349,337 (median EUR 308,400), while 13 purchases weigh only EUR 1,522,814 (median EUR 125,950), which is 4% of open-market trades. The largest sale is Liam Kelly's (Chairman, President & CEO), EUR 5,341,912 on December 27, 2023; Benson Smith (Director) sold EUR 5,051,616 on October 31, 2019, and Thomas Anthony Kennedy (Senior VP, Global Operations) EUR 4,753,015 on September 19, 2018.
Purchases are of another order: EUR 190,877 for John C. Heinmiller (Director) on March 8, 2019, EUR 182,517 for Gretchen R. Haggerty (Director) on June 21, 2017 and EUR 149,065 for Liam Kelly on August 5, 2025. From August 5 to August 6, 2025, five filers bought EUR 546,824.
Thomas E. Powell (Executive Vice President & CFO) signs 147 filings, 87 of them sales, Benson Smith 130, 89 of them sales, and Stephen K. Klasko MD (Director) 83. The year 2018 concentrates 220 filings and 2019 holds 170. For 13 purchases tracked at 90 days, the stored median is 4.6%, with 54% positive: stored past results, not a forecast. The last twelve months hold 22 filings, with no sale or purchase.
Headquarters: Wayne, United States · Founded: 1943 · Wikipedia article
Source: Wikidata (CC0).
| Fiscal year end | Revenue | Net income | Diluted EPS | Dividend per share | Filing |
|---|---|---|---|---|---|
| Dec 2025 | 1.99 bn USD | -905.6 m USD | -20.25 USD | 1.36 USD | 10-K |
| Dec 2024 | 1.70 bn USD | 69.7 m USD | 1.48 USD | 1.36 USD | 10-K |
| Dec 2023 | 1.71 bn USD | 356.3 m USD | 7.53 USD | 1.36 USD | 10-K |
| Dec 2022 | 2.79 bn USD | 363.1 m USD | 7.68 USD | 1.36 USD | 10-K |
| Dec 2021 | 2.81 bn USD | 485.4 m USD | 10.23 USD | 1.36 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.